Delivery Order SPE2DB22D3016-SPE2DB24FALL7
Award Date 2/5/24
Potential Completion Date 2/27/24
Potential Value $47K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $93,538.86 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 1,100 mg/11 ml vials of Ultomiris. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by December 27, 2023. No set-aside designation was applied. As a prime contractor supporting DLA Troop Support Medical programs, Amerisourcebergen...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,285.93 by the Defense Logistics Agency on July 18, 2025, for the supply of Ultomiris 300 mg/3 ml vials. This competitively awarded, firm fixed-price contract has no set-aside designation and is scheduled for completion by August 8, 2025. The award represents a child delivery order under AmerisourceBergen's broader relationship with the DLA, leveraging the company's established...
- The Defense Logistics Agency awarded a $9,558.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ultomiris 300 mg/3 ml vials. This non-competitive delivery order, with an ultimate completion date of September 29, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,420.20 for Ultomiris 300 mg/3 ml vials on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price, competitively awarded contract (No. 4569318413) is being funded by the Defense Logistics Agency's Medical Supply Chain, a Defense Department entity responsible for pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a $50,978.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 ml vials. The award was made on September 11, 2025, with an ultimate completion date of October 2, 2025, and the product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a continuation of the company's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,835.28 firm fixed-price delivery order is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor and there is no indication of set-aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $213,893.00 contract is for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML pharmaceuticals to support military treatment programs and facilities. The award has no set-aside designation and performance will take place at Amerisourcebergen's corporate headquarters in Conshohocken, Pennsylvania....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product, with a ceiling value of $46,826.19. The contract has a firm fixed price pricing type and an ultimate completion date of October 16, 2024. This award is not associated with any set-aside program. Amerisourcebergen, a major supplier of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. The contract has a ceiling value of $26,285.85 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating it was competed on an unrestricted basis. The contract has...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract has a ceiling value of $93,652.38 and an ultimate completion date of July 30, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...